Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
AdvaMed’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
Understanding Regulations in China, Japan and India for Device Expansion and Clinical Operations Excellence
Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices
Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.
AdvaMed members work around the globe, so we do, too.
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
The Chinese government announced a process to export particular devices without NMPA approval.